未知生产厂商
Gantacurium chloride is a new, investigational, non-depolarizing ultra-short acting neuromuscular blocker. It is being developed by Avera Pharmaceuticals.
Gantacurium chloride is a new, investigational, non-depolarizing ultra-short acting neuromuscular blocker. It is being developed by Avera Pharmaceuticals.
Investigated for use/treatment in anesthesia (unspecified).
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
